EPIX ESSA Pharma
- 6.880
- -0.070-1.01%
ESSA Pharma News
We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, ESSA Pharma (NASDAQ:EPIX) shareholders have done very
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
ESSA Pharma(EPIX.US) Officer Sells US$5,510.36 in Common Stock
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 694 shares of Common Stock on Apr 5, 2024 at an average price of $7.94 for a total value of $5,510.36.Source: Announcement What is statement of changes
ESSA Pharma Shareholders Show Strong Support
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
SOUTH SAN FRANCISCO, USA and VANCOUVER, CANADA, March 7, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA" or the "Company") (NASDAQ: EPIX), a clinical stage pharmaceutical company focused on developing
ESSA Pharma(EPIX.US) Officer Sells US$6,232.12 in Common Stocks
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 694 shares of Common Stocks on Mar 5, 2024 at an average price of $8.98 for a total value of $6,232.12.Source: Announcement What is statement of change
Insider Buyers At ESSA Pharma Sitting On US$441k Profit
Insiders who bought ESSA Pharma Inc. (NASDAQ:EPIX) stock lover the last 12 months are probably not as affected by last week's 12% loss. After accounting for the recent loss, the US$709.0k worth of sh
Analysts Offer Insights on Healthcare Companies: ESSA Pharma (EPIX) and Rocket Pharmaceuticals (RCKT)
Analysts Are Bullish on Top Healthcare Stocks: Puma Biotechnology (PBYI), ESSA Pharma (EPIX)
ESSA Pharma: Q1 Earnings Insights
ESSA Pharma (NASDAQ:EPIX) reported its Q1 earnings results on Tuesday, February 13, 2024 at 07:00 AM.Here's what investors need to know about the announcement.EarningsESSA Pharma beat estimated earnin
ESSA Pharma GAAP EPS of -$0.14
Essa Pharma 1Q R&D Expenses $5.4M >EPIX
Essa Pharma 1Q R&D Expenses $5.4M >EPIX
Essa Pharma: Cash Runway Sufficient to Fund Ops Beyond 2025 >EPIX
Essa Pharma: Cash Runway Sufficient to Fund Ops Beyond 2025 >EPIX
Press Release: ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023 Canada NewsWire SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Feb. 13, 2
ESSA Pharma(EPIX.US) Officer Sells US$748.93K in Common Stocks
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 72,782 shares of Common Stocks on Feb 6, 2024 at an average price of $10.29 for a total value of $748.93K.Source: Announcement What is statement of cha
ESSA Pharma(EPIX.US) Officer Sells US$11,439.5 in Common Stocks
$ESSA Pharma(EPIX.US)$ Officer Virsik Peter sold 1,194 shares of Common Stocks on Feb 5, 2024 at an average price of $9.58 for a total value of $11,439.5.Source: Announcement What is statement of chan
ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, Feb. 6, 2024 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on devel
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
ESSA Pharma (NASDAQ:EPIX) has outperformed the market over the past 5 years by 3.09% on an annualized basis producing an average annual return of 15.65%. Currently, ESSA Pharma has a market capitaliza
Analysts Offer Insights on Healthcare Companies: Envista Holdings (NVST), AbbVie (ABBV) and ESSA Pharma (EPIX)
Analysis
Price Target
No Data
